The purpose of this report is to present the economic case for a more structured approach to depression management in the UK. Using techniques from the disciplines of health economics and actuarial science we'll demonstrate cost-effectiveness and return on investment. The results of the model show that from a societal perspective, disease management programmes for depression are likely to both reduce costs and increase quality of life for patients in the overall adult population.